薬物による不眠症におけるジェンダー差の現実世界の分析:FAERSとCVARDDのデータベースからの証拠
Yuntai Wang1,2, Shengjie Wang1,2, Fuxing Liu1,2
1Department of Rehabilitation Medicine, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan City, Hubei Province, China.
Frontiers in neurology
|February 18, 2026
まとめ
この研究では,不眠症を引き起こす多くの薬物を特定し,リスクの有意な性別の違いを強調しました. 早期のモニタリングは,薬物誘発性不眠症 (DII) の管理と患者の安全にとって極めて重要です.
科学分野:
- 医薬品監視 医薬品監視
- 薬物安全 薬物安全
- スリープ・メディシン (睡眠医学)
背景:
- 不眠症は,生活の質に影響を与える一般的な睡眠障害です.
- 薬物誘発性不眠症 (DII) は,二次不眠症の認識されていない原因です.
- D.II.における性別差異に関するデータは限られている.
研究 の 目的:
- 現実世界のデータを用いて,薬物と不眠症の関連性を特定する.
- 薬物による不眠症における性別の違いを評価する.
- 高いリスクの薬物の発見を検証し,発症までの時間を特徴付けます.
主な方法:
- FAERSデータ (2004年−2025年) を用いた遡及的医薬品警戒調査.
- 不釣り合いの分析 (ROR,PRR,BCPNN,MGPS) と性層別比較. 性別別別を重ねて比較した.
- 発症までの時間に関するCVARDDとWeibullモデルでの外部検証.
主要な成果:
- 266,429件の不眠症の報告が確認され,女性 (60.1%) が男性 (32.0%) よりも多く報告した.
- 237の薬剤は,ラベル付けされていないリスクを含む,重要な不眠症シグナルを示した.
- トップ20の薬のうち15の薬は性薬物相互作用が有意であった;TTOは早期発症を示した.
結論:
- 検証された結果を持つ複数の薬物-不眠症信号を特定しました.
- DIIリスクにおける量化された有意な性別の差異.
- DIIを認識し,性に関連した変動性を監視する必要性を強調した.
関連する概念動画
Substance Use Disorders Affecting Sleep
463
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
463
Management of Insomnia
688
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
688
Sedatives and Hypnotics Drugs: Miscellaneous Agents
633
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
633
Blind Procedures
13.7K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.7K
Insomnia
508
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
508
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
394
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
394


